Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

A comparison of the SMAD2 mutations with clinical characteristics of cancers did not reveal an association of mutations with cancer stages, but p.S464Ter showed a trend toward decreased OS of patients with the mutations (Figure 5D ) in pan-cancer and in the individual cancers with >1 p.S464Ter occurrence in informative samples.
In a recent phase 1–2 trial in SOD1-ALS patients, IT administration of Tofersen, a MOE-gapmer ASO targeting SOD1 , significantly reduced SOD1 concentrations in CSF and despite the low number of patients enrolled in the study showed a trend towards slowing disease progression in ASO-treated patients ( 19 ).
Treatment effect on OS in predefined subsets showed a trend for better benefit in: (i) viral vs. non-viral-induced HCC with an unstratified HR (95% CI) of 0.77 (0.56–1.05) for HBV, 0.71 (0.49–1.01) for HCV, and 0.95 (0.74–1.22) for non-viral; (ii) presence (HR 0.74 [0.61–0.90]) vs. absence (HR 1.14 [0.81–1.62]) of macrovascular invasion and/or extrahepatic spread; and (iii) AFP with high baseline level ≥ 200 ng/mL (HR 0.69 [0.53–0.89]) vs. low level < 200 ng/mL (HR 0.99 [0.78–1.26]).
In the work of Salvi et al., correlation (showing the equality line) and Bland–Altman graphs showed a trend that would enable the inference that as PWV increases, cfPWV_Real_SCOR would be gradually greater than aoPWV_Brachial_MOG [ 30 ].
However, dual initiation therapies including high- and low-dose ertugliflozin + sitagliptin and empagliflozin + linagliptin showed a trend of better glycemic control than the oral GLP-1 receptor agonist, although this was not statistically significant.